Download the Article: 'Immuno-oncology; bringing patients closer to treatment'

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment? Even more importantly, what do immunotherapies mean for patients who face diagnosis of advanced cancers? Senior Associate Consultants Frances Hendry and Zoe Bartley tackle these complex questions.

Please enter your details so we can email you the content


Our content has moved

We’re posting all new articles on our parent website fishawack.com

Fishawack Health launches Delta Magazine

Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.

In the precision medicine era, the line between products and services is blurred

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

SIGN UP TO OUR NEWSLETTER TO RECEIVE

  • Our latest articles on industry trends
  • Access to downloadable resources
  • Updates on pharma events and career opportunities
SIGN UP NOW